- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 794970, 13 pages
In Vivo Anti-Influenza Virus Activity of Japanese Herbal (Kampo) Medicine, “Shahakusan,” and Its Possible Mode of Action
1Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
2Department of Drug Discovery Sciences, Kitasato Institute for Life Sciences, Kitasato University, 5-9-1 Shirakane, Minato-ku, Tokyo 108-8641, Japan
3Department of Basic Research, Oriental Medicine Research Center, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan
Received 26 June 2012; Revised 20 November 2012; Accepted 30 November 2012
Academic Editor: Taixiang Wu
Copyright © 2012 Rei Hokari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- WHO Influenza (seasonal), http://www.who.int/mediacentre/factsheets/fs211/en/.
- B. R. Murphy and R. G. Webster, “Orthomyxoviruses,” in Fields Virology, B. N. Fields, D. M. Knipe, and P. M. Howley, Eds., pp. 1397–1445, Lippincott-Raven, New York, NY, USA, 3rd edition, 1996.
- I. Stephenson and K. G. Nicholson, “Chemotherapeutic control of influenza,” Journal of Antimicrobial Chemotherapy, vol. 44, no. 1, pp. 6–10, 1999.
- F. Hayden, “Developing new antiviral agents for influenza treatment: what does the future hold?” Clinical Infectious Diseases, vol. 48, supplement 1, pp. S3–S13, 2009.
- K. Nishimura, G. A. Plotnikoff, and K. Watanabe, “Kampo medicine as an integrative medicine in Japan,” Japan Medical Association Journal, vol. 52, no. 3, pp. 147–149, 2009.
- T. Kubo and H. Nishimura, “Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children,” Phytomedicine, vol. 14, no. 2-3, pp. 96–101, 2007.
- S. Nabeshima, K. Kashiwagi, K. Ajisaka et al., “A comparison of oseltamivir with maoto, a traditional herbal medicine, for the treatment of adult seasonal influenza A,” Journal of Traditional Medicines, vol. 27, no. 4, pp. 148–156, 2010.
- S. Nabeshima, K. Kashiwagi, K. Ajisaka et al., “A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza,” Journal of Infection and Chemotherapy, vol. 18, no. 4, pp. 534–543, 2012.
- Q. Fan and Z. Zhu, Science of Prescriptions, Publishing House of Shanghai University of Traditional Chinese Medicine, Shanghai, China, 2004.
- K. Otsuka and D. Yakazu, Empiric Formulary of Kampo Medicine (Keiken Kampo shohou bunryou shu), Ido-no Nippon Sha, Kanagawa, Japan, 1989.
- C. C. Yeh, C. C. Lin, S. D. Wang, Y. S. Chen, B. H. Su, and S. T. Kao, “Protective and anti-inflammatory effect of a traditional Chinese medicine, Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury,” International Immunopharmacology, vol. 6, no. 9, pp. 1506–1514, 2006.
- I. Y. Choi, H. N. Koo, S. H. Lee et al., “Anti-inflammatory activity of Korean folk medicine “Sabaeksan”,” Experimental and Molecular Pathology, vol. 78, no. 3, pp. 257–262, 2005.
- K. H. Lee, M. H. Yeh, S. T. Kao et al., “Xia-Bai-San inhibits lipopolysaccharide-induced activation of intercellular adhesion molecule-1 and nuclear factor-kappa B in human lung cells,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 530–538, 2009.
- F. M. Davenport, A. V. Hennessy, F. M. Brandon, R. G. Webster, C. D. Barrett, and G. O. Lease, “Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins,” The Journal of Laboratory and Clinical Medicine, vol. 63, no. 1, pp. 5–13, 1964.
- T. Nagai, Y. Nishibe, Y. Makino, T. Tomimori, and H. Yamada, “Enhancement of in vivo anti-influenza virus activity of 5,7,4'- trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose,” Biological and Pharmaceutical Bulletin, vol. 20, no. 10, pp. 1082–1085, 1997.
- W. Watanabe, K. Konno, K. Ijichi, H. Inoue, T. Yokota, and S. Shigeta, “MTT colorimetric assay system for the screening of antiorthomyxo- and anti-paramyxoviral agents,” Journal of Virological Methods, vol. 48, no. 2-3, pp. 257–265, 1994.
- S. I. Tamura, H. Asanuma, Y. Ito et al., “Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine,” European Journal of Immunology, vol. 22, no. 2, pp. 477–481, 1992.
- H. Kiyohara, C. Ichino, Y. Kawamura, T. Nagai, N. Sato, and H. Yamada, “Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth,” Journal of Natural Medicines, vol. 66, no. 1, pp. 55–61, 2012.
- T. Nagai, Y. Shimizu, T. Shirahata et al., “Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata,” International Immunopharmacology, vol. 10, no. 6, pp. 655–661, 2010.
- S. Johann, G. Blümel, M. Lipp, and R. Förster, “A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity,” Journal of Immunological Methods, vol. 185, no. 2, pp. 209–216, 1995.
- S. Makino, S. Ikegami, H. Kano et al., “Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1,” Journal of Dairy Science, vol. 89, no. 8, pp. 2873–2881, 2006.
- N. Nishimura, N. Doi, T. Uemura et al., “Pharmaceutical analysis and clinical efficacy of Kampo medicine, maoto, extract suppository against pediatric febrile symptoms,” Yakugaku Zasshi, vol. 129, no. 6, pp. 759–766, 2009.
- M. Kurokawa, J. I. Yamamura, Z. Li et al., “Antipyretic activity of Gingyo-san, a traditional medicine, in influenza virus-infected mice,” Chemical and Pharmaceutical Bulletin, vol. 46, no. 9, pp. 1444–1447, 1998.
- M. Kobayashi, S. M. Davis, T. Utsunomiya, R. B. Pollard, and F. Suzuki, “Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice,” American Journal of Chinese Medicine, vol. 27, no. 1, pp. 53–62, 1999.
- M. Kurokawa, M. Tsurita, J. Brown, Y. Fukuda, and K. Shiraki, “Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice,” Antiviral Research, vol. 56, no. 2, pp. 183–188, 2002.
- T. Nagai and H. Yamada, “In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to” and its mode of action,” International Journal of Immunopharmacology, vol. 16, no. 8, pp. 605–613, 1994.
- T. Nagai, M. Urata, and H. Yamada, “In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine “Sho-seiryu-to” -effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect,” Immunopharmacology and Immunotoxicology, vol. 18, no. 2, pp. 193–208, 1996.
- H. Yamada and T. Nagai, “In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 20, no. 3, pp. 185–192, 1998.
- K. Mori, T. Kido, H. Daikuhara et al., “Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus,” Antiviral Research, vol. 44, no. 2, pp. 103–111, 1999.
- T. Yokozawa, M. Sekiya, E. J. Cho, M. Kurokawa, and K. Shiraki, “Effect of Wen-Pi-Tang extract on lung damage by influenza virus infection,” Phytomedicine, vol. 11, no. 7-8, pp. 625–632, 2004.
- C. A. Dinarello, “Interleukin-1 in the pathogenesis and treatment of inflammatory diseases,” Blood, vol. 117, no. 14, pp. 3720–3732, 2011.
- C. A. Biron, “Initial and innate responses to viral infections—pattern setting in immunity or disease,” Current Opinion in Microbiology, vol. 2, no. 4, pp. 374–381, 1999.
- C. L. Sokol, G. M. Barton, A. G. Farr, and R. Medzhitov, “A mechanism for the initiation of allergen-induced T helper type 2 responses,” Nature Immunology, vol. 9, no. 3, pp. 310–318, 2008.
- L. V. Rizzo, H. Xu, C. C. Chan, B. Wiggert, and R. R. Caspi, “IL-10 has a protective role in experimental autoimmune uveoretinitis,” International Immunology, vol. 10, no. 6, pp. 807–814, 1998.
- N. Baumgarth, L. Brown, D. Jackson, and A. Kelso, “Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10,” Journal of Virology, vol. 68, no. 11, pp. 7575–7581, 1994.
- T. Hamza, J. B. Barnett, and B. Li, “Interleukin 12 a key immunoregulatory cytokine in infection applications,” International Journal of Molecular Sciences, vol. 11, no. 3, pp. 789–806, 2010.
- I. Julkunen, K. Melén, M. Nyqvist, J. Pirhonen, T. Sareneva, and S. Matikainen, “Inflammatory responses in influenza A virus infection,” Vaccine, vol. 19, no. 1, pp. S32–S37, 2000.
- P. J. Barnes, “The cytokine network in asthma and chronic obstructive pulmonary disease,” Journal of Clinical Investigation, vol. 118, no. 11, pp. 3546–3556, 2008.
- K. P. Lam, Y. T. Chu, C. H. Kuo et al., “Suppressive effects of procaterol on expression of IP-10/CXCL 10 and RANTES/CCL 5 by bronchial epithelial cells,” Inflammation, vol. 34, no. 4, pp. 238–246, 2011.
- D. Proud and R. Leigh, “Epithelial cells and airway diseases,” Immunological Reviews, vol. 242, no. 1, pp. 186–204, 2011.
- E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, “Functions of natural killer cells,” Nature Immunology, vol. 9, no. 5, pp. 503–510, 2008.
- J. McGill, J. W. Heusel, and K. L. Legge, “Innate immune control and regulation of influenza virus infections,” Journal of Leukocyte Biology, vol. 86, no. 4, pp. 803–812, 2009.
- T. Utsunomiya, M. Kobayashi, R. B. Pollard, and F. Suzuki, “Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 3, pp. 551–556, 1997.